These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22116180)

  • 1. [Acquisition of medicines in the Seguro Popular: inefficiency and inequity].
    Murayama-Rendón C
    Gac Med Mex; 2011; 147(6):497-503. PubMed ID: 22116180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seguro popular: achievements and perspectives].
    Chertorivski-Woldenberg S
    Gac Med Mex; 2011; 147(6):487-96. PubMed ID: 22116179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico].
    Knaul FM; Arreola-Ornelas H; Méndez-Carniado O; Bryson-Cahn C; Barofsky J; Maguire R; Miranda M; Sesma S
    Salud Publica Mex; 2007; 49 Suppl 1():S70-87. PubMed ID: 17469400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of budget impact in drug reimbursement decisions.
    Cohen JP; Stolk E; Niezen M
    J Health Polit Policy Law; 2008 Apr; 33(2):225-47. PubMed ID: 18325899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of reimbursement practices of private health insurance companies for pharmaceuticals not covered under the Pharmaceutical Benefits Scheme 2008.
    Lingaratnam SM; Kirsa SW; Mellor JD; Jackson J; Crellin W; Fitzsimons M; Zalcberg JR
    Aust Health Rev; 2011 May; 35(2):204-10. PubMed ID: 21612735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Integration of the delivery of health services].
    Frenk J
    Salud Publica Mex; 1992; 34 Suppl():85-104. PubMed ID: 1411782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of the pharmaceutical expenditure in Hungary].
    Inotai A; Merész G; Kaló Z
    Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equity and health services.
    Bayoumi AM
    J Public Health Policy; 2009 Jul; 30(2):176-82. PubMed ID: 19597449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs in national health insurance: an effective cost containment mechanism.
    Hoff LC
    Hosp Formul; 1978 Jul; 13(7):528-9, 532, 534. PubMed ID: 10308291
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pricing and reimbursement of pharmaceuticals in Italy.
    Folino-Gallo P; Montilla S; Bruzzone M; Martini N
    Eur J Health Econ; 2008 Aug; 9(3):305-10. PubMed ID: 18566845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australia-United States Free Trade Agreement and the Australian Pharmaceutical Benefits Scheme.
    Sainsbury P
    Yale J Health Policy Law Ethics; 2004; 4(2):387-99. PubMed ID: 15536920
    [No Abstract]   [Full Text] [Related]  

  • 13. Could a Wal-Mart PBM succeed?
    Carroll J
    Manag Care; 2008 Apr; 17(4):36-8. PubMed ID: 18464572
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for STD management in developing countries: choice, procurement, cost, and financing.
    Van der Veen F; Fransen L
    Sex Transm Infect; 1998 Jun; 74 Suppl 1():S166-74. PubMed ID: 10023369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When success sours: PBMs under scrutiny.
    Carroll J
    Manag Care; 2002 Sep; 11(9):20-6. PubMed ID: 12369344
    [No Abstract]   [Full Text] [Related]  

  • 16. One-year assessment of joint procurement of pharmaceuticals in the public health sector in Jordan.
    Al-Abbadi I; Qawwas A; Jaafreh M; Abosamen T; Saket M
    Clin Ther; 2009 Jun; 31(6):1335-44. PubMed ID: 19695398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.
    Oortwijn W; Mathijssen J; Banta D
    Health Policy; 2010 May; 95(2-3):174-84. PubMed ID: 20074829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of the health system in Mexico].
    García-Junco Machado D
    Gac Med Mex; 2012; 148(6):518-24. PubMed ID: 23254710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Equity and health].
    Laguna-García J; Fernández de Castro J; Cordera A
    Salud Publica Mex; 1992; 34 Suppl():9-15. PubMed ID: 1411783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.